0.59Open0.89Pre Close38 Volume2.16K Open Interest79.00Strike Price1.93KTurnover47.24%IV4.17%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.65Extrinsic Value100Contract SizeAmericanOptions Type0.2647Delta0.0856Gamma127.43Leverage Ratio-0.1605Theta0.0022Rho33.74Eff Leverage0.0265Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet